trending Market Intelligence /marketintelligence/en/news-insights/trending/fmewabbhc4-o2wltce3f9w2 content esgSubNav
In This List

Atara Biotherapeutics prices $150M offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Atara Biotherapeutics prices $150M offering

Atara Biotherapeutics Inc. priced an offering of 4,285,714 shares at $35 each to raise $150 million in gross proceeds.

The South San Francisco, Calif.-based company, which is developing treatments for cancer, expects to close the offering by March 5 with J.P. Morgan and Cowen acting as joint book-running managers.

Canaccord Genuity Inc. and Mizuho Securities USA LLC are acting as co-managers.

The underwriters have an option to buy up to an additional 642,857 shares.